
Market Research
Optic Nerves Disorder Treatment Market Rises: North America Takes The Helm
By PR Newswire

DUBLIN, Sept. 13, 2023 /PRNewswire/ -- The "Optic Nerves Disorder Treatment Market Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
Key Highlights:
- The Optic Nerves Disorder Treatment Market is poised for significant growth, with a projected 4.5% CAGR by 2027.
- Lifestyle diseases like diabetes, blood pressure, and hypertension are significant contributors to this growth.
- North America takes the lead in the global market share, driven by the robust presence of leading pharmaceutical companies.
- Online retail and e-commerce trends are further supporting market growth.
Optic nerves play a vital role in our vision, connecting retinal cells to the optic chiasm and facilitating the transformation of light into electric impulses for the brain. With lifestyle diseases on the rise due to inactive lifestyles and unhealthy diets, an increase in conditions like multiple sclerosis that result in optic neuritis has been observed. This, in turn, has led to an increased demand for treatments, propelling the market forward. However, potential side effects of treatment drugs may pose challenges.
Segmentation Insights:
- Treatment Type: Among the treatment types, Immunomodulators therapy is expected to dominate, fueled by increasing R&D activities and the launch of new drugs.
- Indication: The glaucoma segment, especially open angle glaucoma, is anticipated to have a substantial share due to the rising incidence of the condition and new drug approvals.
- Distribution Channel: Drug Stores and Retail Pharmacies emerge as leaders in the distribution channel segment, thanks to the proliferation of independent pharmacies and the availability of rare medications in supermarkets.
- Geography: North America leads in global market share, attributed to the vast presence of prominent pharmaceutical and biopharmaceutical entities.
The burgeoning influence of e-commerce is a noteworthy trend, driven by a global shift towards online shopping. Developing nations like China, Brazil, and India are also showcasing increased demand, furthering market growth.
Key Players:
Prominent players in this space include Teva Pharmaceutical Industries Ltd, Bausch Health Companies, Inc., Santen Pharmaceutical Co. Ltd., AbbVie Inc., Novartis AG, Aerie Pharmaceuticals, Inc., Cipla Ltd, Merck & Co. Inc., Mallinckrodt pharmaceuticals, and Pfizer, Inc.
The current scenario offers significant potential for optic nerve disorder treatments, owing to advancements in medical technology, leading to the development of more efficient treatments.
Company Profiles:
- Teva Pharmaceutical Industries Ltd
- Bausch Health Companies, Inc.
- Santen Pharmaceutical Co. Ltd.
- AbbVie Inc.
- Novartis AG
- Aerie Pharmaceuticals, Inc.
- Cipla Ltd
- Merck & Co. Inc.
- mallinckrodt pharmaceuticals
- Pfizer, Inc
For more information about this report visit https://www.researchandmarkets.com/r/lb13go
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/optic-nerves-disorder-treatment-market-rises-north-america-takes-the-helm-301926588.html
SOURCE Research and Markets
First published on Thu, Sep 14, 2023
Enjoyed what you've read so far? Great news - there's more to explore!
Stay up to date with the latest news, a vast collection of tech articles including introductory guides, product reviews, trends and more, thought-provoking interviews, hottest AI blogs and entertaining tech memes.
Plus, get access to branded insights such as informative white papers, intriguing case studies, in-depth reports, enlightening videos and exciting events and webinars from industry-leading global brands.
Dive into TechDogs' treasure trove today and Know Your World of technology!
Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.
Trending PR Newswire
Rockwell Automation Unveils Powerful New Service To Detect And Respond To OT Cyber Threats
By PR Newswire
IBM And Oracle Expand Partnership To Advance Agentic AI And Hybrid Cloud
By PR Newswire
Neptune Software Announces Strategic Shift: Building The AI-Powered Enterprise For SAP And Beyond
By PR Newswire
Abbott Integrates Libre's Data With Epic's Electronic Health Record System, Providing Healthcare Professionals Seamless Glucose Monitoring Information
By PR Newswire
Akamai Firewall For AI Enables Secure AI Applications With Advanced Threat Protection
By PR Newswire
Join Our Newsletter
Get weekly news, engaging articles, and career tips-all free!
By subscribing to our newsletter, you're cool with our terms and conditions and agree to our Privacy Policy.
Join The Discussion